FindTrial
Sign In

A Comparative Evaluation of Patient-Reported Quality of Life Following Combined Minimally Invasive Glaucoma Surgery and Phacoemulsification vs Trabeculectomy with Phacoemulsification in Patients with Glaucoma in Southern India

A Comparative Evaluation of Patient-Reported Quality of Life Using a modified questionnaire based on Indian Visual Function Questionnaire (IND-VFQ-33) along with Glaucoma Symptom scale (GSS) Following Combined Minimally Invasive Glaucoma Surgery and Phacoemulsification vs Trabeculectomy with Phacoemulsification in Patients with Glaucoma in Southern India

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104507
Enrollment
136
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H406- Glaucoma secondary to drugs Health Condition 2: H401- Open-angle glaucoma Health Condition 3: H402- Primary angle-closure glaucoma

Interventions

Control Intervention1: Phacoemulsification with MIGS : We are going to assess change in quality of life between patients undergoing phaco Trabeculectomy with patients undergoing phaco MIGS Control Int

Sponsors

GW Global Health Legacy Fellowship Program
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients diagnosed with primary open-angle glaucoma, juvenile open angle glaucoma, normal tension glaucoma, pigment dispersion glaucoma, secondary angle glaucoma 18 years to 80 years Patients requiring cataract surgery in addition to glaucoma surgery Willing to give written informed consent

Exclusion criteria

Exclusion criteria: Minors, or cognitively impaired individuals who cannot provide informed consent Patients with other significant ocular diseases that might interfere with the study outcomes Patients with angle closure glaucoma, juvenile open angle glaucoma, pigment dispersion glaucoma, pseudoexfoliation glaucoma, uveitic glaucoma Patients who cannot complete a visual field Inability to do follow-up testing and questionnaires Severe glaucoma

Design outcomes

Primary

MeasureTime frame
Patient-reported quality of life using the IND-VFQ-33 and a modified glaucoma symptom scaleTimepoint: Preop, postop day 1, day 15, day 30, 3 month and 6 month—

Secondary

MeasureTime frame
Compare IOP, number of anti-glaucoma medications (AGM), and Humphrey visual field (HFA) parameterTimepoint: baseline,postop day 15, 1 month, 3 months, and 6 months post-op—

Countries

India

Contacts

Public ContactDr Swati Upadhyaya

Aravind Eye Hospital

docswatinirmala@gmail.com8489810704

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026